Home > Insider Trading > Filing (0001193805-19-001904)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1280776	Immunic Inc.	IMUX	Pharmaceutical Preparations (2834)	562358443

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591098	Duane Nash	1200 Avenue Of The Americas, Suite 200 New York NY 10036		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-12-02	22,157	$0.00	22,362	No	4	M	Direct
Common Stock	Disposition	2019-12-03	7,930	$7.15	14,432	No	4	F	Direct
Common Stock	Disposition	2019-12-04	4,400	$6.96	10,032	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2019-12-02	22,157	$0.00	22,157	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
864,159			No	4	M	Direct

Footnotes

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs granted to the Reporting Person.
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $7.1508 and $7.1572 per share.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
On January 11, 2019, the Reporting Person was granted 886,316 restricted stock units as consideration of cancelled stock options. Pursuant to the Reporting Person's amended RSU Agreement, RSUs that vested prior to April 22, 2019 were settled on December 2, 2019.